CLIN RADIOL 2020 10.1016/j.crad.2020.01.002
Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category
Park1, HJ; Kim, YK; Cha, DI; Ko, SE; Kim, S; Lee, ES; Ahn, S

EUR RADIOL 2020 10.1007/s00330-019-06575-0
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
Lee1, MW; Kang, D; Lim, HK; Cho, J; Sinn, DH; Kang, TW; Song, KD; Rhim, H; Cha, DI; Lu, DSK

KOREAN J RADIOL 2020 10.3348/kjr.2019.0538
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients
Cha1, DI; Jang, KM; Kim, SH; Kim, YK; Kim, H; Ahn, SH

EUR RADIOL 2020 10.1007/s00330-020-06753-5
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS
Cha1, DI; Choi, GS; Kim, YK; Kim, JM; Kang, TW; Song, KD; Ahn, SH